Some studies showed that the upregulation of IGFBP2 is often associated with aggressiveness and poor prognosis in glioblastoma and breast cancer through regulation of the β-catenin signaling pathway, which is also responsible for tumor invasion, proliferation and the maintenance of glioma stem cells [17, 25–27]. This evidence concerns the gene IGFBP2 and breast carcinoma.